Clinical Trial

Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer

Study acronym: CELAEC
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 10, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to compare outcomes in Chinese patients with locally advanced resectable esophageal squamous cell cancer who have received either surgery or definitive chemoradiation (CRT) by the randomized, open-label, multicenter trial.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2016-11-21; most recent amendment 2025-02-06.
Status change: Not Yet Recruiting → Recruiting 2017-04-18
Trial Details
NCT Number NCT02972372
Lead Sponsor The First Affiliated Hospital of Henan University of Science and Technology
Collaborators: Jiangsu HengRui Medicine Co., Ltd., Anyang Tumor Hospital, 150th Hospital of PLA
Conditions Esophagus Cancer
Enrollment 196 participants
Start Date 2016-11
Primary Completion 2025-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-02-10